What’s Doximity Inc. (DOCS)’s Price to Earnings Ratio?

Doximity Inc. (NYSE:DOCS) saw an upside of 0.46% to $75.60 after adding $0.35 on Wednesday. The 5-day average trading volume is 2,552,748 shares of the company’s common stock. It has gained $91.25 in the past week. An average of 2,282,062 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 2,331,385.

DOCS’s 1-month performance is -20.76% or -$18.75 on its low of $69.51 reached on 10/12/21. The company’s shares have touched a 52-week low of $41.17 and high of $107.79. YTD, DOCS has achieved 41.98%. However, the current price is down -29.87%% from the 52-week high price.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Insider Transactions

On Aug 13, 61 days have gone by since the last insider trading activity for Doximity Inc. (DOCS). Bryson Anna (Chief Financial Officer) most recently sold 23,359 shares at $75.00 per share on Aug 13. This transaction cost the insider $1,751,948. Chief Commercial Officer, Kleine Joseph B., sold 200,000 shares at a price of $75.77 on Aug 13. Then, on Jun 28, 10% Owner INTERWEST PARTNERS X LP sold 4,289,250 shares at a price of $24.57 per share. This transaction amounted to $105,386,872.

Valuation Metrics

Doximity Inc. (DOCS) has a trailing price-to-earnings (P/E) ratio of 23.70 for the broader industry and 32.24 for the sector.DOCS stock has a beta of 0.00. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 60.24 while the price-to-book (PB) in the most recent quarter is 19.15.

Doximity Inc.’s quick ratio for the period ended June 29 was 7.90, with the current ratio over the same period at 7.90 meaning that DOCS stock is able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.00, while the total debt to equity was 0.00. In terms of profitability, the gross margin trailing 12 months is 87.10%. The trailing 12-month EBITDA margin is 28.97%. The firm’s gross profit as reported stood at $175.7 million against revenue of $206.9 million.

Earnings Surprise

For the quarterly period ending June 29 this year, Analysts expected DOCS to announce $0.08 per share in earnings in its latest quarter, but it posted $0.11, representing a 37.50% surprise. EBITDA for the quarter stood at more than $30.1 million. DOCS stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 101.73 million, with total debt at $0.78 million

Technical Picture

Let’s look briefly at Doximity Inc. (DOCS) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 12 October was 43.33% to suggest the stock is trending Neutral, with historical volatility in this time period at 96.33%.

The stock’s 5-day moving average is $75.71, reflecting a -11.53% or -$9.94 change from its current price. DOCS is currently trading -19.17% above its 20-day SMA. However, the stock’s current price level is away from the SMA50 by +40.72%.

Stochastic %K and %D was 19.24% and 16.53% and the average true range (ATR) pointed at 6.62. The RSI (14) points at 44.71%, while the 14-day stochastic is at 30.84% with the period’s ATR at 6.86. The stock’s 9-day MACD Oscillator is pointing at -3.53 and -5.63 on the 14-day charts.

Analyst Ratings

In the most recent analyst report for Doximity Inc. (NYSE: DOCS), JP Morgan downgraded it to a Neutral rating. They previously had an Overweight rating on the stock. Analysts offering their rating for DOCS stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate DOCS as a “sell,”, while 3 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 1 rates the stock as overweight while 5 have offered a “buy” rating.

What is DOCS’s price target for the next 12 months?

Analysts have a consensus price target ranging from a low of $40.00 and a high of $71.00, with their median price target at $66.50. Looking at these predictions, the average price target given by analysts is for Doximity Inc. (DOCS) stock is $63.50.


Please enter your comment!
Please enter your name here


Hot Topics

Related Videos

Related Videos

Related Articles



Download Free eBook For



100% free. stop anytime no spam